Trials / Completed
CompletedNCT02196948
Electrolysis Percutaneous Therapeutic (EPTE) for Supraspinatus Tendinopathy
Electrolysis Percutaneous Therapeutic (EPTE) for the Management of Supraspinatus Tendinopathy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Universidad Rey Juan Carlos · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Therapeutic management of supraspinatus tendinopathy is conflicting. There is evidence that eccentric exercise protocols can be effective for this condition. The inclusion of other therapeutic modalities could help to the management of these patients. A new therapeutic approach, called Electrolysis Percutaneous Therapeutic (EPTE) has been clinically developed. The objective of this randomized clinical trial is to determine the effectiveness of the inclusion of EPTE into a eccentric exercise protocol for the management of patients with unilateral supraspinatus tendinopathy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Electrolysis Percutaneous Therapeutic (EPTE) | |
| OTHER | Eccentric exercise |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-07-22
- Last updated
- 2014-12-03
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02196948. Inclusion in this directory is not an endorsement.